Trial intelligence / Profile preview

Testosterone support after military field exercise

2026-525935-18-01Phase 2Authorised

Sponsor
Norwegian School of Sport Sciences
Start
Oct 2026
Countries
1
01

Overview

Phase 2, randomised trial comparing Testosterone undecanoate with Placebo (2 arms). Primary endpoints: Recovery of countermovement jump height, Recovery of lower-body explosive performance and 3 more. Planned start Oct 2026; status: authorised.

02

Drugs

testosterone undecanoate

Beyond the preview

Go deeper on 2026-525935-18-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2026-525935-18-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call